AS

Anjali Singh

Active Director Director DIN 02552510
DIN 02552510 First appointment Jun 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2009
Shareholding value •••• Premium profile

About Anjali Singh

Data last updated:

Anjali Singh is a Director at Mercury Nursing Home And Medipharma Private Limited (since 2009). The company operates in Healthcare. Mercury Nursing Home And Medipharma Private Limited reported revenue of ₹1.4 Lakh (FY 2025).

DIN 02552510
Primary Designation Director
Industry Healthcare
First Appointment 15 Jun 2009
Oldest Company Age 17 yrs
Largest company Mercury Nursing Home And Medipharma Private Limited · ₹1.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 20092009₹1.4 Lakh (FY 2025)Active

Board colleagues of Anjali Singh

Directorship timeline

Open interactive timeline →
Mercury Nursing Home And Medipharma Private Limited
Premium access

Shareholding and investment profile for Anjali Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Singh

Anjali Singh currently holds 1 directorship: Mercury Nursing Home And Medipharma Private Limited (Director, since 15 Jun 2009, revenue ₹1.4 Lakh (FY 2025)).

Anjali Singh was first appointed on 15 Jun 2009 as Director at Mercury Nursing Home And Medipharma Private Limited.

The current boards of Anjali Singh's companies include Dhruv Kumar Singh (Mercury Nursing Home And Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available